LIVE MARKET TRACKER :   BSE SENSEX   31713.56      |    NSE NIFTY 9890.45    
GLOBAL MARKETS :  NASDAQ 6426.922   +0.066%    |    FSI London 7310.64   +0.64%    |    NIKKEI Japan 20385.76   +0.44%
  USD GBP EUR CAD AUD INR
USD - 0.7392 0.8381 1.2331 1.2571 64.7500
GBP 1.3532 - 1.1336 1.6680 1.7002 87.6050
EUR 1.1936 0.8823 - 1.4716 1.5000 77.2873
CAD 0.8112 0.6000 0.6797 - 1.0197 52.5480
AUD 0.7958 0.5883 0.6668 0.9812 - 51.5270
INR 0.0154 0.0114 0.0129 0.0191 0.0194 -
Indian-Commodity  :  Equity & Shares  :  Glenmark gains on entering into exclusive agreement with Cyndea Pharma

Glenmark gains on entering into exclusive agreement with Cyndea Pharma (19-Jul-2017)

Glenmark Pharmaceuticals is currently trading at Rs. 697.35, up by 5.70 points or 0.82% from its previous closing of Rs. 691.65 on the BSE.

The scrip opened at Rs. 692.00 and has touched a high and low of Rs. 699.50 and Rs. 692.00 respectively. So far 3,985 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 993.00 on 01-Nov-2016 and a 52 week low of Rs. 600.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 699.50 and Rs. 677.00 respectively. The current market cap of the company is Rs. 19,638.00 crore.

The promoters holding in the company stood at 46.50%, while Institutions and Non-Institutions held 40.80% and 12.70% respectively.

Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing generic, soft-gelatin capsule formulations of certain pharmaceutical products.

Under this agreement, Glenmark receives exclusive rights to the United States and Canada markets for these soft-gelatin formulations in exchange for sharing development costs and profits from future sales. In addition, the agreement provides for the companies to add further soft-gelatin product candidates for development and commercialization, as new branded, soft gelatin, capsule-based drug products become available in the marketplace.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of oncology, dermatology and respiratory.



Top News Today
Zydus Cadila, Oberoi Realty and Artefact Projects to see some action today
(25-Sep-2017)

Zydus Cadila, Oberoi Realty and Artefact Projects to see some action todayZydus Cadila has received the final approval from the USFDA to market Amlodipine and Olmesartan Medoxomil Tablets in strengths of 5 mg/20 mg, 5 mg/40 mg 10 mg/20 mg, and 10 mg/40 mg. The drug is indicated......click on news to read complete article.

REC gets nod to raise Rs 65,000 crore via bonds
(23-Sep-2017)

REC gets nod to raise Rs 65,000 crore via bondsRural Electrification Corporation (REC) has received shareholders' approval to raise up to Rs 65,000 crore via bonds over the next one year. The special resolution was passed at the company's annual general......click on news to read complete article.

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.com
(23-Sep-2017)

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.comBNP Paribas Arbitrage has sold 1.40 lakh shares of Matrimony.com. The fund house has offloaded the same at Rs 817.73 on the NSE on September 22, 2017.Recently, BNP Paribas Arbitrage has offloaded 1,34,102......click on news to read complete article.

International Stock News
US markets end flat on geopolitical concerns
(23-Sep-2017)

US markets end flat on geopolitical concernsThe US markets ended the lackluster session near their neutral lines on Friday on geopolitical concerns amid an escalating war of words between North Korean leader Kim Jong Un and President Donald Trump.......click on news to read complete article.

Asian markets trade lower on heightened geopolitical tensions
(22-Sep-2017)

Asian markets trade lower on heightened geopolitical tensionsThe Asian markets are showing a weak trend on Friday, on renewed geopolitical worries after a report that North Korea could respond to fresh sanctions with a hydrogen bomb in the Pacific. A news report......click on news to read complete article.

US markets closed lower; Dow snaps nine-day winning streak
(22-Sep-2017)

US markets closed lower; Dow snaps nine-day winning streakThe US markets closed lower on Thursday, with the Dow snapping a nine-day winning streak as investors found few reasons to chase equities a day after the Federal Reserve indicated it still intends to deliver......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.